Search results
Results: 88
Number of items: 88
-
Kummer, L. Y. L., Kuijper, L. H., Fernández Blanco, L., Bos, A., Kreher, C., Verstegen, N. J. M., Duurland, M. C., Konijn, V. A. L., Jorritsma, T., Tempert, M., Menage, C., Steenhuis, M., van Gils, M. J., Claireaux, M., Garcia-Vallejo, J. J., D’Haens, G. R. A. M., Löwenberg, M., Volkers, A. G., van Dam, K. P. J., ... ten Brinke, A. (2025). TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination. RMD OPEN, 11(3), Article e005724. https://doi.org/10.1136/rmdopen-2025-005724 -
Keijzer, S., Oskam, N., Ooijevaar-de Heer, P., Steenhuis, M., Keijser, J. B. D., Wieske, L., van Dam, K. P. J., Stalman, E. W., Kummer, L. Y. L., Boekel, L., Kuijpers, T. W., ten Brinke, A., van Ham, S. M., Eftimov, F., Tas, S. W., Wolbink, G. J., Rispens, T., & T2B! immunity against SARS-CoV-2 study group (2024). Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection. Frontiers in Immunology, 15, Article 1314507. https://doi.org/10.3389/fimmu.2024.1314507
-
van den Dijssel, J., van Ham, S. M., ten Brinke, A., & T2B! immunity against SARS-CoV-2 study group (2024). mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses. Journal of autoimmunity, 144, Article 103175. https://doi.org/10.1016/j.jaut.2024.103175
-
Verkerk, T., Pappot, A. T., Jorritsma, T., King, L. A., Duurland, M. C., Spaapen, R. M., & van Ham, S. M. (2024). Isolation and expansion of pure and functional γδ T cells. Frontiers in Immunology, 15, Article 1336870. https://doi.org/10.3389/fimmu.2024.1336870
-
van Dam, K. P. J., Wieske, L., Stalman, E. W., Kummer, L. Y. L., van der Kooi, A. J., Raaphorst, J., van de Beek, D., Verschuuren, J. J. G. M., Ruiter, A. M., Brusse, E., van Doorn, P. A., Baars, A. E., van der Pol, W. L., Goedee, H. S., ten Brinke, A., van Ham, S. M., Rispens, T., Kuijpers, T. W., Eftimov, F., & the T2B! Immunity Against SARS-CoV-2 Study Group (2024). Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseases. European Journal of Neurology, 31(12), Article e16409. https://doi.org/10.1111/ene.16409
-
Verstegen, N. J. M., Hagen, R. R., Kreher, C., Kuijper, L. H., Dijssel, J. V. D., Ashhurst, T., Kummer, L. Y. L., Palomares Cabeza, V., Steenhuis, M., Duurland, M. C., Jongh, R. D., Schoot, C. E. V. D., Konijn, V. A. L., Mul, E., Kedzierska, K., van Dam, K. P. J., Stalman, E. W., Boekel, L., Wolbink, G., ... T2B! immunity against SARS-CoV-2 study group (2024). T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination. Journal of Neurology, Neurosurgery and Psychiatry, 95(9), 855–864. https://doi.org/10.1136/jnnp-2023-332224
-
Kuijper, L. H., Kreher, C., Elias, G., Claireaux, M., Kerster, G., Bos, A. V., Duurland, M. C., Konijn, V. A. L., Paul, A. G. A., de Jong, N., de Jongh, R., Steenhuis, M., Garcia-Vallejo, J. J., van Gils, M. J., Kuijpers, T. W., Eftimov, F., Rispens, T., van der Schoot, C. E., van Ham, S. M., & ten Brinke, A. (2024). Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection. Frontiers in Immunology, 15, Article 1505719. https://doi.org/10.3389/fimmu.2024.1505719
-
Verstegen, N. J. M., Jorritsma, T., ten Brinke, A., Barberis, M., & van Ham, S. M. (2024). TCR-CD3 signal strength regulates plastic coexpression of IL-4 and IFN-γ in Tfh-like cells. Frontiers in Immunology, 15, Article 1481243. https://doi.org/10.3389/fimmu.2024.1481243
Page 2 of 9